Results from first 59 leukemia patients who received investigational, personalized cellular therapy

Three and a half years after beginning a clinical trial that demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies.